← SynDRA
TENOFOVIR ANHYDROUS
SynDRA canonical compound SYN0000385 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | FOLH1 |
| Mechanism of action | glutamate receptor antagonist |
All known targets
- HBcAg
- HIV RT
- pol
- reverse transcriptas
Mechanisms of action (all sources)
- HIV integrase inhibitor
- nucleoside reverse transcriptase inhibitor
- Inhibitor
Drug classes
- Anti-HIV Agents
- Anti-Infective Agents
- Anti-Retroviral Agents
- Antiviral Agents
- Enzyme Inhibitors
- Nucleic Acid Synthesis Inhibitors
- Reverse Transcriptase Inhibitors
Cross-references
Synonyms
- tenofovir
- tenofovir hydrate
- tenefovir
- GS-1275
- Tenofovir
- Apropovir
- PMPA
- TFV
- Tenefovir
- GS 1275
- GS 1278
- GS1278
- GNA & Tenofovir
- HHA & Tenofovir
- KS-5021
- Viread (TN)
- Viread, Tenofovir
- D,L-Tenofovir
- PMPA-(R)
- Phosphonic acid, [[2-(6-amino-9H-purin-9
- [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid
- Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-(9CI)
- Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Galanthus nivalis agglutinin (GNA)
- Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Hippeastrum hybrid agglutinin(HHA)
- (R)-9-(2-Phosphonomethoxypropyl)adenine
- (R)-9-(2-Phosphonylmethoxypropyl)adenine
- (R)-PMPA
- W4HFE001U5
- tenofovir monohydrate
- tenofovir (usp-rs)
- TENOFOVIR
- Tenofovir hydrate
- PMP-A
- GS-1278
- 9-((R)-2-PHOSPHONOMETHOXY-PROPYL)ADENINE MONOHYDRATE
- tenofovir (anhydrous)
- anhydrous tenofovir
- tenofovir (anh.)
- CHEBI:63625
Look up TENOFOVIR ANHYDROUS in the interactive SynDRA portal →